Caravan Biologix Company Profile, Contacts & Intelligence
Caravan Biologix Overview
CAR-Directed BioSpheres (Mini-CAR) are innovative therapeutic agents that emulate the functions of T cells, Natural Killer cells, or macrophages. These miniaturized biospheres, derived from an allogeneic parent cell, house chimeric antigen receptors (CARs) and optional checkpoint inhibition tags. This unique design enables highly targeted and safe release of apoptotic proteins to diseased cells, offering a promising solution to the limitations of conventional CAR whole cell therapies in treating a variety of diseases, including solid tumor cancers and hereditary disease.
- Headquarters
- Princeton, Nj, United States
- Website
- www.caravanbio.com
- Industry
- Biotechnology Research
- Founded
- 2020
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Caravan Biologix Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Caravan Biologix People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Caravan Biologix Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to Caravan Biologix
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| KBP Biosciences | Pharmaceutical Manufacturing | 47 | View company |
| Tulex Pharmaceuticals Inc. | Pharmaceutical Manufacturing | 28 | View company |
| AcousticaBio | Biotechnology | 15 | View company |
| Chimeron Bio | Biotechnology Research | 11 | View company |
| 4M Therapeutics Inc. | Biotechnology Research | 5 | View company |
| Colorado Health & Tech Centers | Real Estate | 4 | View company |
| Kermode Biotechnologies | Biotechnology Research | 4 | View company |
| CILA THERAPEUTICS | Biotechnology Research | 3 | View company |
| Summit Impact Partners | Venture Capital And Private Equity Principals | 3 | View company |
| KOMO Biosciences | Biotechnology Research | 2 | View company |